Skip to main navigation Skip to search Skip to main content

Advanced antisense oligonucleotide technology for Exon skipping in Duchenne Muscular Dystrophy

Project: Research

Project Details

StatusFinished
Effective start/end date1/02/11 → 31/01/14

Funding

  • Wellcome Trust: £224,780.00